Skip to main content

Table 1 Baseline characteristics for 409 patients with idiopathic pulmonary fibrosis

From: Potential interstitial lung abnormalities on chest X-rays prior to symptoms of idiopathic pulmonary fibrosis

Total patients

409

Male (%)

313 (77)

Median age at diagnosis (IQR)

68.2 (62.0–74.5)

First-degree family member with pulmonary fibrosis (%)

116 (28)

Other family member with pulmonary fibrosis (%)

24 (6)

Current smoker (%)

33 (8)

Former smoker (%)

298 (73)

Never smoker (%)

78 (19)

Significant exposure to asbestos, dusts, fumes, or radiation (%)

79 (9)

Gastro-oesophageal reflux (%)

149 (36)

Cardiovascular disease (%)

188 (46)

Initial symptoms

 

 Cough

284 (69)

 Dyspnoea

343 (84)

 No respiratory complaints

9 (2)

 Evaluation in context of screening of family members of patients with familial pulmonary fibrosis

5 (1)

Chest X-ray done prior to start of symptoms (%)

96 (23)

 Showing potential interstitial lung abnormalities (%)

56 (58)

CT-imaging done prior to start of symptoms (%)

44 (11)

 Showing interstitial lung abnormalities or pulmonary fibrosis (%)

34 (77)

Symptoms started directly after infectious episode (%)

40 (10)

Symptoms started directly after surgery (%)

5 (1)

Treatment with steroids prior to diagnosis (%) #

103 (25)

Treatment with other immunosuppressant prior to diagnosis (%)

23 (6)

Other ILD diagnosis prior to diagnosis of IPF (%)

67 (16)

Cardiology workup for symptoms prior to pulmonology visit (%)

45 (11)

Time from start of symptoms to first visit with pulmonologist, median months (IQR)

5.0 (2.0–12.0)

Time from first visit with pulmonologist to start of symptoms, median months (IQR)

10.0 (4.0–33.0)

Time from start of symptoms to diagnosis, median months (IQR)

24.0 (9.0–48.0)

Forced vital capacity at diagnosis, median percentage of predicted (IQR)

78.1 (64.0–91.3)

Diffusion capacity for carbon monoxide at diagnosis, median percentage of predicted (IQR)

41.0 (32.0–51.0)

Radiographic pattern at diagnosis

 UIP pattern (%)

238 (58)

 Probable UIP (%)

101 (25)

 Inconsistent with UIP or indeterminate for UIP (%)

70 (17)

Histology pattern at diagnosis

99 (24)

 UIP pattern (%) *

70 (70)

 Probable UIP (%) *

16 (16)

 Inconsistent with UIP or indeterminate for UIP (%) *

13 (13)

Consensus diagnosis of IPF (%)

190 (47)

Received treatment with antifibrotic therapy after diagnosis (%)

331 (81)

  1. #Prednisolone equivalent >  = 10 mg/daily for > 4 weeks
  2. *Percentages represent the percentage of the patients in whom lung biopsy specimens were available